Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stopping Imatinib Therapy in CML Patients With Sustained Molecular Remission

NCT03062436 is registered in ClinicalTrials.gov with Command Hospital, India as lead sponsor.

NCT NCT03062436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03062436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stopping Imatinib Therapy in CML Patients With Sustained Molecular Remission
Lead sponsor
Command Hospital, India
Phase
Not applicable
Overall status
Unknown status
Start date
August 1, 2017
Completion date
December 31, 2020
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia, treatment free remission